Search research articles
Contact Us
Filters
Showing results (131-140 of 264) with videos related to
Page
of 27
Sort By:
Journal of Psychopharmacology (Oxford, England)
|
August 9, 2013
Mood stabilizer treatment increases serotonin type 1A receptor binding in bipolar depression
Allison C Nugent, Paul J Carlson, Earle E Bain, et al.
Biological Psychiatry
|
April 30, 2005
Selective reduction in amygdala volume in pediatric anxiety disorders: a voxel-based morphometry investigation
Michael P Milham, Allison C Nugent, Wayne C Drevets, et al.
Journal of Affective Disorders
|
December 2, 2020
Meaningful Change in Depression Symptoms Assessed with the Patient Health Questionnaire (PHQ-9) and Montgomery-Åsberg Depression Rating Scale (MADRS) Among Patients with Treatment Resistant Depression in Two, Randomized, Double-blind, Active-controlled Trials of Esketamine Nasal Spray Combined With a New Oral Antidepressant
Stacie Hudgens, Lysbeth Floden, Michael Blackowicz, et al.
Biological Psychiatry
|
May 7, 2017
Real-Time Functional Magnetic Resonance Imaging Amygdala Neurofeedback Changes Positive Information Processing in Major Depressive Disorder
Kymberly D Young, Masaya Misaki, Catherine J Harmer, et al.
Biological Psychiatry
|
July 27, 2005
Normal prefrontal gamma-aminobutyric acid levels in remitted depressed subjects determined by proton magnetic resonance spectroscopy
Gregor Hasler, Alexander Neumeister, Jan Willem van der Veen, et al.
Neuropsychiatric Disease and Treatment
|
January 1, 2024
A Meta-Analysis of the Antidepressant Responses in Pivotal Trials on Esketamine Nasal Spray and Atypical Antipsychotics
Lien Wang, Xiaowei Chen, Xiaojing Gu, et al.
Biological Psychiatry
|
August 7, 2007
Elevated serotonin transporter binding in major depressive disorder assessed using positron emission tomography and [11C]DASB; comparison with bipolar disorder
Dara M Cannon, Masanori Ichise, Denise Rollis, et al.
Journal of the American Academy of Child and Adolescent Psychiatry
|
September 27, 2015
A neural substrate for behavioral inhibition in the risk for major depressive disorder
Julie Frost Bellgowan, Peter Molfese, Michael Marx, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
January 30, 2026
Efficacy and safety of adjunctive treatment with the fatty acid amide hydrolase inhibitor JNJ-42165279 in participants with major depressive disorder with anxious distress: A double-blind, placebo-controlled, randomised study
Mark E Schmidt, Cynthia Gargano, Xianhuang Zhou, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
November 3, 2006
Choosing the lesser of two evils, the better of two goods: specifying the roles of ventromedial prefrontal cortex and dorsal anterior cingulate in object choice
Karina Blair, Abigail A Marsh, John Morton, et al.
Page
of 27
Search research articles
Search
Showing results (131-140 of 264) with videos related to
Sort By:
Page
of 27
Journal of Psychopharmacology (Oxford, England)
|
August 9, 2013
Mood stabilizer treatment increases serotonin type 1A receptor binding in bipolar depression
Allison C Nugent, Paul J Carlson, Earle E Bain, et al.
Biological Psychiatry
|
April 30, 2005
Selective reduction in amygdala volume in pediatric anxiety disorders: a voxel-based morphometry investigation
Michael P Milham, Allison C Nugent, Wayne C Drevets, et al.
Journal of Affective Disorders
|
December 2, 2020
Meaningful Change in Depression Symptoms Assessed with the Patient Health Questionnaire (PHQ-9) and Montgomery-Åsberg Depression Rating Scale (MADRS) Among Patients with Treatment Resistant Depression in Two, Randomized, Double-blind, Active-controlled Trials of Esketamine Nasal Spray Combined With a New Oral Antidepressant
Stacie Hudgens, Lysbeth Floden, Michael Blackowicz, et al.
Biological Psychiatry
|
May 7, 2017
Real-Time Functional Magnetic Resonance Imaging Amygdala Neurofeedback Changes Positive Information Processing in Major Depressive Disorder
Kymberly D Young, Masaya Misaki, Catherine J Harmer, et al.
Biological Psychiatry
|
July 27, 2005
Normal prefrontal gamma-aminobutyric acid levels in remitted depressed subjects determined by proton magnetic resonance spectroscopy
Gregor Hasler, Alexander Neumeister, Jan Willem van der Veen, et al.
Neuropsychiatric Disease and Treatment
|
January 1, 2024
A Meta-Analysis of the Antidepressant Responses in Pivotal Trials on Esketamine Nasal Spray and Atypical Antipsychotics
Lien Wang, Xiaowei Chen, Xiaojing Gu, et al.
Biological Psychiatry
|
August 7, 2007
Elevated serotonin transporter binding in major depressive disorder assessed using positron emission tomography and [11C]DASB; comparison with bipolar disorder
Dara M Cannon, Masanori Ichise, Denise Rollis, et al.
Journal of the American Academy of Child and Adolescent Psychiatry
|
September 27, 2015
A neural substrate for behavioral inhibition in the risk for major depressive disorder
Julie Frost Bellgowan, Peter Molfese, Michael Marx, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
January 30, 2026
Efficacy and safety of adjunctive treatment with the fatty acid amide hydrolase inhibitor JNJ-42165279 in participants with major depressive disorder with anxious distress: A double-blind, placebo-controlled, randomised study
Mark E Schmidt, Cynthia Gargano, Xianhuang Zhou, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
November 3, 2006
Choosing the lesser of two evils, the better of two goods: specifying the roles of ventromedial prefrontal cortex and dorsal anterior cingulate in object choice
Karina Blair, Abigail A Marsh, John Morton, et al.
Page
of 27